Brief: Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
25/06/2025 12:50
June 25 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE ENROLLS FIRST PATIENT IN ITS CLINICAL TRIAL FOR ALCOHOLISM TREATMENT Source text: ID:nGNX2yMM6T Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM